Rab 39B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Rab 39B protein. Rab 39B is a member of the Rab family of small GTPases, which are critical regulators of intracellular vesicle trafficking. These proteins switch between an active GTP-bound form and an inactive GDP-bound form, playing a key role in processes such as endocytosis, exocytosis, and intracellular transport. Rab 39B is particularly involved in the regulation of vesicle trafficking between the Golgi apparatus and endosomes, as well as the transport of specific cargo proteins, such as those involved in maintaining cellular homeostasis and signaling pathways. By inhibiting Rab 39B activity, these compounds can modulate vesicular transport and protein sorting within cells, making them useful for studying various cellular processes.
Chemically, Rab 39B inhibitors are diverse in structure, encompassing a range of small molecules that can bind to Rab 39B with high specificity. They work by interfering with the GTPase's ability to bind and hydrolyze GTP, disrupting its normal function and downstream signaling. This interference can lead to alterations in vesicle formation, trafficking, and cargo delivery, which in turn can impact a variety of cellular mechanisms. These inhibitors are valuable in cellular biology research, as they allow for the dissection of Rab 39B's role in vesicle trafficking and the broader Rab GTPase signaling network. Moreover, due to the specific role of Rab 39B in cellular vesicle dynamics, these inhibitors can serve as important tools for elucidating the molecular mechanisms underlying intracellular transport, protein trafficking, and the regulatory pathways associated with Rab GTPases.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. It can demethylate DNA and activate gene expression, but in certain contexts, might reduce the expression of specific genes like Rab-39B by altering methylation patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. By changing the acetylation status of histones, it can influence gene expression, potentially downregulating genes like Rab-39B. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA synthesis. This could lead to a general reduction in protein expression, including Rab-39B. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and inhibits transcription. This non-selective inhibition could potentially reduce Rab-39B expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus is an mTOR inhibitor. By inhibiting mTOR signaling, it can reduce protein synthesis in cells, potentially reducing Rab-39B expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis by targeting ribosomes. This could lead to reduced Rab-39B protein levels, albeit in a non-specific manner. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II, preventing mRNA synthesis. This broad action might reduce the expression of many genes, including Rab-39B. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
Tamoxifen is known to influence gene expression profiles in certain cell types. Its effects on Rab-39B are hypothetical, but it might alter its expression through complex signaling cascades. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, which can lead to altered gene expression profiles. This might result in decreased Rab-39B expression in specific contexts. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. By inhibiting JNK pathways, it might influence the expression of several genes, possibly including Rab-39B. | ||||||